PCH
ORIC icon

Polar Capital Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Polar Capital Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-539,377
Closed -$6.83M – 262
2026
Q1 		$6.83M Buy
539,377
+37,013
+7% +$420K 0.02% 205
2025
Q4 		$4.11M Buy
502,364
+33,754
+7% +$389K 0.02% 233
2025
Q3 		$5.62M Buy
+468,610
New +$4.93M 0.03% 218

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Polar Capital Holdings's ORIC Position: Q2 2026 in Review

Polar Capital Holdings sold out of Oric Pharmaceuticals (ORIC) in Q2 2026, closing a stake of 539,377 shares — an estimated $6.83M sold.

Polar Capital Holdings first reported a position in ORIC in Q3 2025 and held it in 3 quarters. The position peaked at $6.83M in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Polar Capital Holdings reported no remaining Oric Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Polar Capital Holdings sold 539,377 Oric Pharmaceuticals shares in Q2 2026, an estimated $6.83M.
  • Polar Capital Holdings first reported a position in Oric Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Polar Capital Holdings's Oric Pharmaceuticals position peaked at $6.83M in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.